Cargando…
Investigating the safety and efficacy of hematopoietic and mesenchymal stem cell transplantation for treatment of T1DM: a systematic review and meta-analysis
BACKGROUND: Stem cell transplantation (SCT) has paved the way for treatment of autoimmune diseases. SCT has been investigated in type 1 diabetes mellitus (T1DM) as an autoimmune-based disorder, but previous studies have not presented a comprehensive view of its effect on treatment of T1DM. METHODOLO...
Autores principales: | Madani, Sedigheh, Amanzadi, Mahdiyeh, Aghayan, Hamid Reza, Setudeh, Aria, Rezaei, Negar, Rouhifard, Mahtab, Larijani, Bagher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9059401/ https://www.ncbi.nlm.nih.gov/pubmed/35501872 http://dx.doi.org/10.1186/s13643-022-01950-3 |
Ejemplares similares
-
Safety and efficacy of hematopoietic and mesanchymal stem cell therapy for treatment of T1DM: a systematic review and meta-analysis protocol
por: Madani, Sedigheh, et al.
Publicado: (2018) -
Co-transplantation of Human Fetal Mesenchymal and Hematopoietic Stem Cells in Type 1 Diabetic Mice Model
por: Arjmand, Babak, et al.
Publicado: (2019) -
Xeno-free protocol for GMP-compliant manufacturing of human fetal pancreas-derived mesenchymal stem cells
por: Jabbarpour, Zahra, et al.
Publicado: (2022) -
Efficacy of adipose tissue-derived stem cells in locomotion recovery after spinal cord injury: a systematic review and meta-analysis on animal studies
por: Rafiei Alavi, Seyedeh Niloufar, et al.
Publicado: (2021) -
A global, regional, and national survey on burden and Quality of Care Index (QCI) of bladder cancer: The global burden of disease study 1990–2019
por: Karimi, Amirali, et al.
Publicado: (2022)